{"id":14214,"date":"2009-10-27T11:31:34","date_gmt":"2009-10-27T10:31:34","guid":{"rendered":"http:\/\/miunidad.eu\/porib.com\/?p=14214"},"modified":"2021-09-13T12:06:08","modified_gmt":"2021-09-13T10:06:08","slug":"sanchez-carazo-jl-dauden-e-vanaclocha-f-toribio-j-pujol-r-puig-ll-yebenes-m-sabater-fj","status":"publish","type":"post","link":"https:\/\/porib.com\/en\/sanchez-carazo-jl-dauden-e-vanaclocha-f-toribio-j-pujol-r-puig-ll-yebenes-m-sabater-fj\/","title":{"rendered":"Sanchez-Carazo JL, Dauden E, Vanaclocha F, Toribio J, Pujol R Puig Ll, Y\u00e9benes M, Sabater FJ"},"content":{"rendered":"<div class=\"col80\">\n<p class=\"miniatura_foto\" style=\"text-align: justify;\"><strong><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-14157 alignleft\" src=\"https:\/\/porib.com\/wp-content\/uploads\/2021\/09\/ISPOR.jpg\" alt=\"\" width=\"120\" height=\"120\" \/>Sanchez-Carazo JL, Dauden E, Vanaclocha F, Toribio J, Pujol R Puig Ll, Y\u00e9benes M, Sabater FJ<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<div class=\"col80p\">\n<h6 style=\"text-align: justify;\">Cost of moderate to severe psoriasis patients in Spain<\/h6>\n<h6 style=\"text-align: justify;\"><strong>12th Annual European Congress International Society for Pharmacoeconomics &amp; Outcomes Research (ISPOR). Paris, France. 24-27 oct 2009<\/strong><\/h6>\n<p><a href=\"https:\/\/porib.com\/wp-content\/uploads\/2009\/10\/59.pdf\" target=\"_blank\" rel=\"noopener\">POSTER<\/a><\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Sanchez-Carazo JL, Dauden E, Vanaclocha F, Toribio J, Pujol R Puig Ll, Y\u00e9benes M, Sabater FJ &nbsp; &nbsp; Cost of moderate to severe psoriasis patients in Spain 12th Annual European Congress International Society for Pharmacoeconomics &amp; Outcomes Research (ISPOR). Paris, France. 24-27 oct 2009 POSTER<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"quote","meta":{"footnotes":""},"categories":[938,919,246],"tags":[],"class_list":["post-14214","post","type-post","status-publish","format-quote","hentry","category-costes-de-la-enfermedad-tipo-de-proyecto","category-enfermedades-autoinmunes","category-international-society-of-pharmacoeconomics-and-outcomes-research","post_format-post-format-quote"],"translation":{"provider":"WPGlobus","version":"2.10.3","language":"en","enabled_languages":["es","en"],"languages":{"es":{"title":true,"content":true,"excerpt":false},"en":{"title":false,"content":false,"excerpt":false}}},"_links":{"self":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/14214"}],"collection":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/comments?post=14214"}],"version-history":[{"count":3,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/14214\/revisions"}],"predecessor-version":[{"id":14244,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/14214\/revisions\/14244"}],"wp:attachment":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/media?parent=14214"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/categories?post=14214"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/tags?post=14214"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}